ResMed (RMD) Posts Q1 EPS of $0.36, Tops by 4c
ResMed (NYSE: RMD) reports Q1 EPS of $0.36, 4 cents better than the analyst estimate of $0.32. Revenue for the quarter was $282.0 million, which compares to the estimate of $280.65 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Cuts Price Target on ResMed (RMD) to $56 Following 1Q Miss
- Exelon Corp. (EXC) Tops Q3 EPS by 12c
- W.R. Grace & Co. (GRA) Tops Q3 EPS by 4c, Revenue Misses
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!